| abstract |
FIELD: biotechnology. n SUBSTANCE: the invention relates to producing new peptides and may be used for treatment and prophylaxis of cytokine-sensitive disorders. Peptides, having a size of 5 to 40 amino acids and arising from cytokines, are used in a vaccine for treatment and prophylaxis of autoimmune diseases, disseminated sclerosis, rheumatoid polyarthritis, psoriasis, autoimmune diabeteses, lupus, allergy, asthma, cancer and AIDS. n EFFECT: allows effective immunization of patients against said diseases while minimizing side effects. n 11 cl, 2 dwg, 17 tbl |